Literature DB >> 22306271

Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood.

Mahmood Naderi1, Mahdi Paryan, Kayhan Azadmanesh, Houshang Rafatpanah, Houri Rezvan, Siamak Mirab Samiee.   

Abstract

BACKGROUND: Proviral load quantification of human T-lymphotropic virus type 1 (HTLV-1) is an essential marker for disease progression. Therefore, accurate and precise quantification of the virus is important. However, many articles published about detection and quantification of HTLV-1 virus neither reported any databank for the pre-validation of their primer and probe sequences nor stressed on its importance. Consequently, this failure may cause proviral load measurement variations of different HTLV-1 strains.
OBJECTIVE: The aim of this study was to develop a TaqMan assay for HTLV-1 proviral load quantification which is based on a conserved region of tax gene with minimal sequence variability. STUDY
DESIGN: For the purpose of finding the most conserved region of tax gene, all the HTLV-1 Gene Bank records including tax gene sequence (524 records by December 2009) were aligned in order to design on the most conserved region of this gene. The specificity, sensitivity, inter and intra assay and the dynamic range of the assay were experimentally determined by their respective methodology. RESULT: The assay has a dynamic range of 10-10(7) HTLV-1 plasmid DNA/rxn (reaction) and the limit of detection (LOD) less than 10 copies/rxn. The assay gave coefficient of variation (CV) for the Ct values of less than 1% and 4.8% for intra and inter assay, respectively. Clinical sensitivity and specificity were determined to be 97.8% and 100%, respectively.
CONCLUSION: This TaqMan assay is able to reliably quantify proviral load due to the fact that it has been designed on a conserved region of HTLV-1 tax gene with minimal sequence variability. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306271     DOI: 10.1016/j.jcv.2011.12.033

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  11 in total

1.  Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.

Authors:  A Cucca; L Stragapede; L Antonutti; M Catalan; I Caracciolo; Romina Valentinotti; A Granato; P D'Agaro; P Manganotti
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

2.  Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR.

Authors:  Evandra Strazza Rodrigues; Suellen Salustiano; Elaine Vieira Santos; Svetoslav Nanev Slavov; Virgínia Picanço-Castro; Juliana Matos Maçonetto; Tissiana Marques de Haes; Osvaldo Massaiti Takayanagui; Dimas Tadeu Covas; Simone Kashima
Journal:  J Neurovirol       Date:  2022-01-13       Impact factor: 2.643

3.  Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology.

Authors:  Rodrigo Pessôa; Jaqueline Tomoko Watanabe; Youko Nukui; Juliana Pereira; Jorge Casseb; Jorge Kasseb; Augusto César Penalva de Oliveira; Aluisio Cotrim Segurado; Sabri Saeed Sanabani
Journal:  PLoS One       Date:  2014-03-31       Impact factor: 3.240

4.  Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.

Authors:  Yuyang Tang; Alvin M George; Oksana Petrechko; Franklin J Nouvet; Stephanie D Sweet; Yuetsu Tanaka; Brian S Imbiakha; Guochun Jiang; Wei Gao; Kathryn Anastos; James E K Hildreth
Journal:  mSphere       Date:  2018-04-04       Impact factor: 4.389

5.  A novel medium-throughput biological assay system for HTLV-1 infectivity and drug discovery.

Authors:  Mojtaba Fattahi Abdizadeh; Manoochehr Makvandi; Alireza Samarbafzadeh; Kayhan Azadmanesh
Journal:  Iran J Basic Med Sci       Date:  2017-10       Impact factor: 2.699

6.  LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription.

Authors:  Hei-Man Vincent Tang; Wei-Wei Gao; Ching-Ping Chan; Yeung-Tung Siu; Chi-Ming Wong; Kin-Hang Kok; Yick-Pang Ching; Hiroshi Takemori; Dong-Yan Jin
Journal:  Retrovirology       Date:  2013-04-11       Impact factor: 4.602

7.  Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.

Authors:  Rosita Vakili; Faezeh Sabet; Sanaz Aahmadi; Reza Boostani; Houshang Rafatpanah; Ali Shamsian; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

8.  Assessment of HTLV-I proviral load, HIV viral load and CD4 T cell count in infected subjects; with an emphasis on viral replication in co-infection.

Authors:  Hossein Rahimi; Seyyed Abdolrahim Rezaee; Narges Valizade; Rosita Vakili; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2014-01       Impact factor: 2.699

9.  Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers.

Authors:  Mohammad Mehdi Akbarin; Hossein Rahimi; Tahereh Hassannia; Ghazaleh Shoja Razavi; Faezeh Sabet; Abbas Shirdel
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

Review 10.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.